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The p42/p44 mitogen-activated protein kinase
(MAPK) cascade includes Ras, Raf, Mek, and
Erk MAPK. To determine the effect of a full
knockout at a single level of this signaling path-
way in mammals, and to investigate functional
redundancy between Mek1 and Mek2, we dis-
rupted these genes in murine and human epi-
dermis. Loss of either protein alone produced
no phenotype, whereas combined Mek1/2 de-
letion in development or adulthood abolished
Erk1/2 phosphorylation and led to hypoprolif-
eration, apoptosis, skin barrier defects, and
death. Conversely, a single copy of either allele
was sufficient for normal development. Com-
bined Mek1/2 loss also abolished Raf-induced
hyperproliferation. Human tissue deficient in ei-
ther Mek isoform was normal, whereas loss of
both proteins led to hypoplasia, which was res-
cued by active Erk2 expression. These data in-
dicate that Mek1/2 are functionally redundant
in the epidermis, where they act as a linear relay
in the MAPK pathway to mediate development
and homeostasis.
INTRODUCTION
The extracellular signal-regulated kinase (Erk) mitogen-
activated protein kinase (MAPK) cascade is conserved in
mammals and is controlled by a variety of upstream signal-
ing inputs, the best characterized of which include the Ras
family of GTPases (Roux and Blenis, 2004). Ras-depen-
dent activation of Erk MAPK proceeds via Raf MAPK ki-
nase kinase (Raf MAPKKK) and Mek MAPK kinase (Mek
MAPKK) signaling to exert a pleiotropic array of cellular ef-
fects (Murphy and Blenis, 2006). Erk MAPK activation has
been associated with human disease, including up to 30%
of all cancers (Hoshino et al., 1999), and experimental in-
duction of the pathway can promote tumorigenesis in
mammalian tissues (Dajee et al., 2003; Hahn and Wein-Develoberg, 2002; Lundberg et al., 2002). Recently, activating
mutations inMEK1 andMEK2 have been identified and as-
sociated with the rare dominant autosomal cardio-facio-
cutaneous (CFC) syndrome (Niihori et al., 2006; Rodri-
guez-Viciana et al., 2006). Mutations in KRAS and BRAF
can also cause this disorder. The similarity in CFC pheno-
types induced by these mutations both suggests func-
tional congruency of these Erk MAPK components in hu-
mans and underscores the importance of the Erk MAPK
pathway as a primary Ras target among other canonical
Ras effectors, such as the Ral and phosphatidylinositol-
3-kinase pathways. The impact of impaired Ras-Raf-
Mek-Erk signaling is less well understood, however, be-
cause loss-of-function analysis has been complicated by
the existence of multiple isoforms at each level of the cas-
cade. Indeed, simultaneous loss of all isoforms at any one
level of the cascade has not been reported in mammals.
At the level of Ras there are H-Ras, N-Ras, and two
alternatively spliced K-Ras isoforms (Mor and Philips,
2006). No abnormal phenotype is observed in H-Ras-,
N-Ras-, or H-Ras/N-Ras-deficient mice, suggesting sig-
nificant functional redundancy (Esteban et al., 2001; Ise
et al., 2000; Umanoff et al., 1995); K-Ras knockout mice,
however, die in embryogenesis (Johnson et al., 1997).
The mammalian Raf MAPKKK gene family consists of
A-Raf, B-Raf, and Raf-1, which, like the Ras isoforms, ap-
pear to possess overlapping as well as isoform-specific
functions. A-Raf knockout mice are viable but have gas-
trointestinal and neurological defects (Pritchard et al.,
1996). In contrast, B-Raf-deficient mice die in midgesta-
tion due to vascular abnormalities (Wojnowski et al.,
1997) and Raf-1 knockout mice are lethal due to placental
defects (Mikula et al., 2001; Wiese et al., 2001; Wojnowski
et al., 1998). Interestingly, lethality in Raf-1 null mice can
be rescued by knockin of a kinase-dead Raf-1 incapable
of phosphorylating Mek MAPKKs (Huser et al., 2001), indi-
cating that Erk MAPK signaling components might func-
tion not only as kinase relays but also by other mecha-
nisms outside the MAPK cascade.
At the Mek MAPKK level, only two isoforms exist, Mek1
and Mek2, which share 80% amino acid identity. Mek1 and
Mek2 interact with a variety of scaffolding and inhibitor
proteins, such as KSR, MP1, p14, RKIP, GIT1, and
IQGAP1, which can regulate the intensity and duration ofpmental Cell 12, 615–629, April 2007 ª2007 Elsevier Inc. 615
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Disruption of Mek1 and Mek2 in TissueErk MAPK signals (Dard and Peter, 2006; Kolch, 2005). The
substantial sequence identity between Mek1 and Mek2, as
well as the fact that they act similarly in most experimental
settings, suggest that they may be functionally redundant
(Kolch, 2000). However, Mek2 knockout mice are pheno-
typically normal, whereas Mek1 knockout mice die at em-
bryonic day (E) 10.5 due to abnormal development and in-
sufficient vascularization of the placenta (Belanger et al.,
2003; Bissonauth et al., 2006; Giroux et al., 1999). Interest-
ingly, Erk knockout mice exhibit a similar disparity in phe-
notype: Erk2 knockout mice are embryonic lethal due to
placental defects (Hatano et al., 2003; Saba-El-Leil et al.,
2003), whereas Erk1 knockout mice are viable (Nekrasova
et al., 2005). These data, along with the observation that
Erk1 knockout mice display hyperplastic skin and cutane-
ous lesions, suggest that MAPK cascade signaling might
be routed through specific isoforms in certain settings.
At present, the only known Mek1/2 targets are Erk1 and
Erk2 MAPKs, which are activated by Mek1/2-dependent
serine and tyrosine phosphorylation. The degree to which
active Erk1/2 can mediate all Mek1/2 functions, however,
is unknown. Activated Erks phosphorylate at least 160 tar-
gets, including nuclear transcription factors and cytosolic
enzymes (Yoon and Seger, 2006). While inferred to func-
tion as a linear pathway, the Erk MAPK cascade, like
many other signaling systems, is subject to complex feed-
back input, and whether any step in the pathway functions
solely as a linear relay is unknown. Most experimental
analysis of this pathway, however, has relied on overex-
pression and pharmacologic approaches in vitro and
has yielded results that were sometimes contradictory,
underscoring the need for genetic loss-of-function studies
in vivo.
Here we examine the effects of Erk MAPK cascade loss
of function by generating mouse and human epidermis
lacking Mek1/2. We show that neither Mek1 nor Mek2
alone is essential for murine epidermal development or
homeostasis. Combined deletion of Mek1/2, however,
leads to abnormal epidermal development, tissue hypo-
plasia, marked epidermal barrier defects, and perinatal
death. Furthermore, deletion of Mek1/2 in adult mouse
skin causes rapid epidermal apoptosis and lethality, indi-
cating that Mek function is required for survival during
adulthood. Mek1/2 are also required for proliferation in-
duced by Raf activation. Combined downregulation of
both Mek proteins via RNA interference led to hypoplasia
in regenerated human epidermal tissue. This defect could
be rescued by active Erk2 expression, underscoring the
importance of Erk MAPK cascade function mediated by
Mek1/2. These findings indicate that the Erk MAPK path-
way is critical for epidermal development and homeosta-
sis in mammals.
RESULTS
Loss of Mek1 or Mek2 Alone Does Not Affect Tissue
Development or Homeostasis
To investigate the roles of Mek1 and Mek2 in mammalian
tissue, we studied mouse epidermis, a self-renewing616 Developmental Cell 12, 615–629, April 2007 ª2007 Elsevierstratified epithelium. Mice carrying one (Mek1fl/+) or two
(Mek1fl/fl) floxed Mek1 alleles were crossed with trans-
genic mice expressing Cre recombinase under the control
of the keratin 14 promoter, thereby generating mice in
which Mek1 is inactivated specifically in epidermal kerati-
nocytes (Bissonauth et al., 2006; Vasioukhin et al., 1999).
To study Mek2, we examined the skin of Mek2 knockout
(Mek2/) mice (Belanger et al., 2003). Expression of
Mek1 and Mek2 was assessed in newborn epidermal ex-
tracts, which confirmed efficient Cre-mediated disruption
of Mek1 and verified that the Mek2 null allele generated no
protein product (see Figure S1A in the Supplemental Data
available with this article online). In contrast to Mek1
knockout mice, which die during embryogenesis (Giroux
et al., 1999), skin-restricted Mek1 knockout mice were vi-
able. Both skin-restricted Mek1 knockout mice and Mek2
null mice were born at normal Mendelian ratios and sur-
vived to adulthood. Furthermore, both histological and
immunofluorescence analyses of newborn mouse skin
revealed no differences between knockout mice and
wild-type controls (Figures S1B and S1C). In adulthood,
Mek1 and Mek2 knockout epidermis remained indistin-
guishable from controls, displaying normal histology as
well as normal patterns of b4 integrin, keratin 5, keratin
10, and loricrin expression (Figures S2A and S2B). In an ef-
fort to unmask more subtle abnormalities, wound healing
capacity was also assessed. Mek1fl/fl, Mek1fl/+Cre, and
Mek1fl/flCre animals exhibited equivalent rates of full-
thickness excisional wound closure, as did wild-type,
Mek2+/, and Mek2/ mice (Figures S1D and S1E). Fur-
thermore, knockout mice healed incisional wounds at
rates indistinguishable from those of wild-type controls.
Thus, epidermal development, homeostasis, and wound
healing are not disrupted by the absence of either Mek1
or Mek2 alone.
CombinedMek1 andMek2 Loss during Development
Leads to Tissue Hypoplasia and Death
To generate tissue lacking both Mek isoforms, Mek1fl/+
Mek2/Cre or Mek1fl/flMek2+/Cre mice were bred to
Mek1fl/flMek2/ animals. Of the resulting progeny, new-
born mice carrying only one wild-type Mek allele—
Mek1fl/+Mek2/Cre and Mek1fl/flMek2+/Cre mice—
were indistinguishable from their wild-type littermates.
Mek1fl/flMek2/Cre double knockout animals, however,
were slightly smaller and had shiny, translucent skin
(Figure 1A). Additionally, double knockout animals were
born with detached ear flaps and, in some cases, open
eyes. All double knockout mice died within 24 hr after
birth. Mek1fl/flMek2/Cre double knockout mice lacked
epidermal expression of both Mek1 and Mek2 proteins.
Erk1/2 phosphorylation was observed in the presence of
one Mek allele—whether Mek1 or Mek2—but was absent
when all four alleles were eliminated, indicating that Mek1
and Mek2 are the only kinases that phosphorylate Erk1
and Erk2 in this context (Figure 1B). The absence of
Mek1 and Mek2 proteins in knockout animals was further
confirmed by immunofluorescence analysis of newborn
skin samples (Figure 1C).Inc.
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Disruption of Mek1 and Mek2 in TissueFigure 1. Mek1/2 Double Knockout Mice Display Skin and Tongue Hypoplasia
(A) Appearance of newborn double knockout mice and two littermates. Double knockout mice have thin, shiny skin and occasionally display open
eyes at birth (arrow).
(B) Western blot of epidermal extracts from newborn mice.
(C) Mek1 and Mek2 protein (orange) detection in newborn skin tissue. Hoechst 33342 (blue). The scale bar represents 50 mm.
(D) Histology of newborn mouse head skin and tongue. Note marked hypoplasia of interfollicular epidermis in double knockout Mek1fl/flMek2/Cre
mice, abnormal hair follicle morphology, and full-thickness tissue death of tongue epithelium. The scale bar represents 50 mm.Developmental Cell 12, 615–629, April 2007 ª2007 Elsevier Inc. 617
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Disruption of Mek1 and Mek2 in TissueFigure 2. Perinatal Lethality and Defective Barrier Function in Mek1/2 Double Knockout Mice
(A) Summary of survival data. Genotypes are noted at the top of each column above the percentage of mice surviving at each time point. The few adult
Mek1fl/flMek2/Cre mice obtained did not excise floxed alleles.
(B) Mean transepidermal water loss in newborn mouse skin (n = 3 independent mice per genotype ± SD).
(C) Weight of newborn mice during 6 hr fasting period. Every line represents an individual mouse, with weights reported relative to the initial birth
weight of each mouse.
(D) Appearance of newborn mice after an overnight incubation in X-gal solution. Blue staining indicates epidermal permeability to X-gal dye. Double
knockout mice exhibit darker and extended X-gal staining on their limbs and near their eyes and ears (black arrows), as well as an open eye and open
ears (white arrows).618 Developmental Cell 12, 615–629, April 2007 ª2007 Elsevier Inc.
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Disruption of Mek1 and Mek2 in TissueAt birth, the surface epithelium of mice lacking both
Mek1 and Mek2 displayed marked abnormalities. Double
knockout epidermis was hypoplastic and displayed few
hair follicles, with 37% fewer pelage follicles and 90%
fewer vibrissae follicles than normal (Figure 1D). All epider-
mal layers, including the stratum corneum and granulo-
sum, were present; however, the less differentiated basal
and squamous layers appeared markedly diminished
(Figure S2C). Tongue epithelium of newborn double
knockout mice displayed full-thickness death and detach-
ment from the underlying tissue; tongues of all the other
genotypes were indistinguishable from wild-type controls
(Figure 1D). Thus, skin and tongue epithelium in double
knockout mice exhibit substantial defects at birth.
Mek1/2 Double Knockout Mice Die Perinatally
with Compromised Barrier Function
To establish the time point at which the combined loss of
Mek1 and Mek2 compromises mouse viability, we geno-
typed progeny of crosses between Mek1fl/+Mek2/Cre
or Mek1fl/flMek2+/Cre and Mek1fl/flMek2/ mice during
embryogenesis, at birth, and 3 weeks after birth. Although
the expected Mendelian ratio (25%) was observed during
embryogenesis and at birth, the vast majority of Mek1fl/fl
Mek2/Cre double knockout mice died within 24 hr after
birth (Figure 2A). The fewMek1fl/flMek2/Cre animals that
survived to 3 weeks of age did not properly excise the
Mek1 gene, as assessed by PCR, and were therefore
not true double knockout animals. In spite of tongue ab-
normalities, double knockout mice were initially able to
nurse and displayed gastric milk contents, suggesting
that skin abnormalities, in addition to mucosal defects,
may contribute to perinatal lethality.
To investigate the epidermal abnormalities observed in
double knockout mice, we examined barrier function in
newborn mouse skin. Transepidermal water loss of mice
retaining one or more wild-typeMek1 orMek2 alleles aver-
aged 5 g/m2/hr, equivalent to that of wild-type controls,
whereas mice lacking all four Mek alleles lost water at an
average of 19 g/m2/hr, indicative of a major epidermal bar-
rier defect (Figure 2B). We next measured newborn weight
over a 6 hr monitored fasting period. Double knockout
mice lost 4%–10% of birth weight over this period,
whereas mice that retained at least one Mek allele main-
tained at least 98% of their birth weight (Figure 2C), indicat-
ing that substantial dehydration occurs in double knockout
mice. Third, we performed an X-gal dye assay to test the
ability of newborn mouse skin to prevent the penetration
of exogenous molecules. Animals carrying one or more in-
tactMek alleles exhibited faint blue staining only near their
whiskers, whereas double knockout newborns showed
substantially darker and extended staining of the whisker
region, as well as staining around the eyes, ears, and all
four limbs (Figure 2D). The increased permeability of dou-
ble knockout skin was already apparent in embryogenesisDeveloat all time points after the establishment of the epidermal
barrier at E17.5 (Figure S3). Although hypoplastic, new-
born double knockout epidermis expressed basal epider-
mal markers such as keratin 14 and suprabasal markers
keratin 10 and loricrin; however, gaps in differentiation
markers were present (Figures 2E and 2F). Together, these
experiments indicate that Mek1/2 double knockout mice
display clinically significant disruption of cutaneous barrier
function associated with defects in epidermal structure.
Mek1/2 Double Knockout Defects Are Tissue
Intrinsic
The perinatal death of Mek1fl/flMek2/Cre double knock-
out mice hindered efforts to observe their phenotype over
time. To determine whether double knockout epidermis
would be viable in the context of an otherwise normal an-
imal, we isolated skin from newborn mice and grafted it
onto immune-deficient CB-17 scid mice. Every double
knockout skin graft failed within 2 weeks, whereas all
grafts expressing at least one Mek allele remained viable
(Figures S4A and S4B). Clinical and histological analysis
of the grafts expressing at least one Mek allele revealed
normal skin architecture and thickness, hair follicle for-
mation, and epidermal differentiation, whereas double
knockout grafts displayed tissue death and loss of hair
follicles (Figure S4C). Therefore, double knockout epider-
mis displays a tissue-intrinsic defect in viability that cannot
be rescued by transplantation.
Mek1/2 Double Knockout Epidermis
Is Hypoproliferative
To further study the basis for the observed defects in
Mek1fl/flMek2/Cre double knockout epidermis, we
analyzed epidermal proliferation and apoptosis. Double
knockout newborn mouse skin was hypoplastic, with ap-
proximately one-third as many epidermal cells per 50 mm
of basement membrane as controls (Figure 3A). However,
proliferation of newborn double knockout epidermis, as
assessed by Ki-67 staining, was not significantly reduced
compared to controls (Figures 3B and 3C), and a TUNEL
assay failed to identify apoptotic cells in newborn skin of
any genotype.
To investigate whether the reduced epidermal cell num-
ber seen in double knockout mice at birth might arise
during embryogenesis, E15.5, E16.5, E17.5, and E18.5
embryos were collected and analyzed for mitotic and apo-
ptotic indices. During embryogenesis, Mek1fl/flMek2/
Credouble knockout animals manifest the phenotypes ap-
parent in newborn mice, including detached ears, reduced
hair follicle number (Figure S5A), and, in some mice, open
eyes (Figure 3D). Differences in cell death were detected at
E17.5, when Mek1fl/flMek2/Cre embryos had more
TUNEL-positive keratinocytes than wild-type or Mek1fl/fl
Mek2/ littermates; these apoptotic cells were largely
seen in the basal layer, and not in hair follicles (Figures(E) Distribution of keratin 10 and keratin 14 (orange); Hoechst 33342 (blue). Note gaps in keratin 10 in double knockout skin (white arrows). The scale
bar represents 50 mm.
(F) Loricrin expression (orange). Note gaps in loricrin in double knockout skin (white arrows); Hoechst 33342 (blue). The scale bar represents 50 mm.pmental Cell 12, 615–629, April 2007 ª2007 Elsevier Inc. 619
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Disruption of Mek1 and Mek2 in TissueFigure 3. Mek1/2 Double Knockout Mice Exhibit Reduced Proliferation and Increased Apoptosis during Embryogenesis
(A) Mean epidermal cell number per 50 mm of basement membrane in newborn mice (n = 3 independent mice per genotype ± SD).
(B) Mean mitotic index of newborn mouse epidermis (n = 3 independent mice per genotype ± SD).
(C) Ki-67 staining in newborn skin. The scale bar represents 50 mm.620 Developmental Cell 12, 615–629, April 2007 ª2007 Elsevier Inc.
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Disruption of Mek1 and Mek2 in Tissue3E and 3F). In addition, epidermal proliferation was re-
duced in Mek1fl/flMek2/Cre embryos at all embryonic
time points assessed (Figure 3G). Similarly, Mek1fl/fl
Mek2/Cre hair follicle cells displayed a statistically
significant reduction in proliferation throughout embryo-
genesis, as compared to controls (Figure S5B). These
data indicate that absence of Mek1/2 leads to decreased
epidermal proliferation and increased apoptosis during
development.
Inducible Deletion of Mek1/2 in Adult Mouse Skin
Results in Apoptosis
The observation of abnormal mitotic and apoptotic indices
in embryonic but not newborn Mek1/2 double knockout
epidermis raised the question as to whether Mek1/2 are re-
quired solely during development. To examine the effect of
Mek1/2 loss in adult epidermis, we crossed Mek1fl/fl
Mek2/ mice to mice expressing 4-hydroxytamoxifen
(4OHT)-regulated Cre recombinase (CreER) under the
control of the keratin 14 promoter, thereby generating
Mek1fl/flMek2/CreERmice, in whichMek1 can be condi-
tionally deleted in epidermis on a Mek2 null background.
Mek1fl/flMek2/CreER animals were born at expected
Mendelian ratios and were phenotypically normal. To dis-
rupt Mek1 expression in these mice, 4OHT was applied
to shaved dorsal skin daily for 4 consecutive days. Lack
of Mek1 and Mek2 protein expression was confirmed by
western blotting (Figure 4A). Neither 4OHT nor ethanol dil-
uent treatment affected the histology of Mek1fl/flMek2/
control skin. In contrast, treatment of Mek1fl/flMek2/
CreER epidermis with 4OHT, but not ethanol, induced epi-
dermal hypoplasia accompanied by epidermal cell death
(Figure 4B). This effect was also observed in the tongue
epithelium of Mek1fl/flMek2/CreER mice, due to 4OHT
exposure via grooming or systemic absorption. Staining
of Ki-67 revealed epidermal proliferation to be dramatically
reduced in 4OHT-treatedMek1fl/flMek2/CreER skin, and
TUNEL assay confirmed the induction of keratinocyte
apoptosis in all layers of the epidermis (Figure 4C).
We next assessed apoptotic markers characteristic of
the mitochondrial and the death receptor pathways. Ac-
tive caspase 9, active caspase 3, and cytochrome c re-
lease were detected in 4OHT-treated Mek1fl/flMek2/
CreER epidermis, but not in controls. Active caspase 8,
however, was not observed following either treatment.
Furthermore, levels of phosphorylated BAD, but not of to-
tal BAD, were reduced in 4OHT-treated Mek1fl/flMek2/
CreER skin (Figure 4C). Together, these data demonstrate
that epidermal cell death occurring with disruption of
Mek1 and Mek2 is accompanied by alterations in proteins
associated with the mitochondrial cell death pathway andDeveloconfirm that Mek1/2 expression is required for epidermal
viability in adult mice.
Mek1fl/flMek2/CreER Skin Grafts Fail after
Inducible Mek1 Deletion
In adult mice, inducible epidermalMek1deletion on aMek2
null background led todeath withina week.To study longer-
term effects of Mek1/2 ablation in adult skin, we grafted
adult mouse skin onto immune-deficient mice. Dorsal skin
was harvested from Mek1fl/flMek2/CreER and Mek1fl/fl
Mek2/ mice. Two skin pieces, each from a different
mouse, were grafted onto individual CB-17 scid mice.
This procedure was performed in duplicate to generate
pairs of identicalmice.Aftergraft healing 4 months later, an-
imals were shaved, and for each pair of identical mice, one
was treated with 4OHT and the other with ethanol. Exten-
sive epidermal erosions and eschar formation were evident
by 14 days of 4OHT treatment in Mek1fl/flMek2/CreER
grafts. This progressed over the next 7 days to skin graft
loss; control grafts remained viable, however, with hair
growth as indicated by darker allograft hair coloration
(Figure S6). Thus, prolonged loss of Mek1 and Mek2 in adult
mouse epidermis leads to epidermal tissue death.
Combined Loss of Mek1 and Mek2 Inhibits
Oncogenic Raf-Induced Hyperplasia
To further investigate the extent to which Mek1/2 disrup-
tion abrogates Erk MAPK cascade signaling, we analyzed
the effect of Raf activation in the context of adult murine
epidermis lacking Mek1, Mek2, or both proteins. Consis-
tent with previous results (Tarutani et al., 2003), activation
of an ER-regulated active Raf-1 protein by 5 days of top-
ical 4OHT treatment led to massive hyperplasia in wild-
type skin. Similar hyperplasia was observed upon Raf ac-
tivation in either skin-restricted Mek1 knockout or Mek2
null epidermis. In all cases, Raf-induced hyperplasia was
marked by increases in mitotic activity as well as the ex-
pression of b4 integrin and the proliferation-associated
keratin 6. In contrast, Raf activation in Mek1/2 double
knockout skin did not induce epidermal hyperplasia, nor
did it increase b4 integrin expression. Furthermore, Raf
activation did not rescue the hypoproliferation and apo-
ptosis characteristic of double knockout skin (Figure 5).
Together, these data show that combined deletion of
Mek1 and Mek2 disrupts the epidermal response to Raf-
mediated signals for hyperproliferation.
Mek1/2-Deficient Human Tissue Displays
Hypoplasia that Can Be Rescued by Active Erk2
To determine whether Mek deficiency in human tissue ex-
erts effects similar to those in mice, we used RNAi to(D) Appearance of double knockout embryos and their littermates at embryonic day 17.5 (E17.5). Note that double knockout embryos exhibit open
ears and an open eye (white arrows).
(E) Increased apoptosis and decreased proliferation in E17.5 double knockout epidermis. TUNEL-positive cells appear primarily in the basal layer
(orange, upper panel), and only in Mek1fl/flMek2/Cre double knockout mice. Mek1/2 double knockout epidermis exhibits decreased Ki-67 staining
in basal layer cells (brown nuclei, lower panel) as compared to control skin. The scale bars represent 50 mm.
(F) Quantitation of TUNEL-positive epidermal cells at E17.5 (n = 3 independent mice per genotype ± SD).
(G) Mitotic index of embryonic skin from E15.5 to E18.5 (n = 3 independent mice per genotype ± SD).pmental Cell 12, 615–629, April 2007 ª2007 Elsevier Inc. 621
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Disruption of Mek1 and Mek2 in TissueFigure 4. Combined Disruption of Mek1 and Mek2 in Adult Murine Epidermis Induces Cell Death
(A) Keratinocyte extracts of the noted genotypes, after treatment with either 4OHT or ethanol diluent control, were probed with the antibodies indi-
cated at left.
(B) Histology of adult mouse skin and tongue epithelium after 4 days of treatment with 4OHT or ethanol. Note the hypoplasia and region of cell debris in
epidermis and the thinning and cell death in tongue epithelium. The scale bar represents 50 mm.
(C) Apoptotic and proliferation markers. Adult mouse skin of the genotypes noted at the top of each column were stained with markers indicated at
right. The scale bar represents 50 mm.622 Developmental Cell 12, 615–629, April 2007 ª2007 Elsevier Inc.
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Disruption of Mek1 and Mek2 in TissueFigure 5. Mek1/2 Double Knockout Tissue Fails to Proliferate in Response to Raf Activation
Histology and immunofluorescence staining of adult mouse skin after 5 days of topical treatment with 4OHT. Genotypes studied are noted at the top
of each column and markers stained are noted at right. The scale bars represent 50 mm.generate Mek1/2-deficient human epidermis. Electropo-
ration of small interfering RNA (siRNA) oligomers targeting
Mek1 and Mek2 into normal primary human keratinocy-
tes led to loss of Mek1 and Mek2 protein expression
(Figure 6A) that persisted for 1 week. These cells were
used to regenerate human epidermal tissue on human der-
mis, which was grafted onto immune deficient mice. Six
days after grafting, keratinocytes treated with scrambled
control siRNA, Mek1 siRNA, or Mek2 siRNA had regener-
ated full-thickness human epidermis. In contrast, com-
bined introduction of both Mek1 and Mek2 siRNA led to
either graft failure or a markedly hypoplastic epidermis
that nonetheless contained an intact stratum corneum
(Figure 6C). Human species-specific antibody to desmo-
glein 3 confirmed that studied tissue was of human origin.DeveloImmunostaining of the basal and suprabasal layer markers
keratin 5 and 10 demonstrated the presence of both layers,
albeit hypoplastic, in Mek1/2-deficient human epidermis.
Human epidermal tissue lacking both Mek1 and Mek2 dis-
played significantly fewer proliferating cells (Figures 6B
and 6C); no TUNEL-positive cells were seen in any grafts.
Therefore, deficiency of Mek1/2 in human epidermis leads
to hypoproliferation and hypoplasia. To determine whether
the epidermal impacts of Mek1/2 deficiency could be res-
cued by restoring function of the Erk MAPK signaling cas-
cade downstream of Mek, we expressed active Erk2 in the
context of combined Mek1/2 knockdown (Figure 7A). Erk2
expression rescued the hypoplasia and hypoproliferation
associated with Mek1/2 deficiency (Figures 7B and 7C),
indicating that absent Mek1/2 MAPKK function can bepmental Cell 12, 615–629, April 2007 ª2007 Elsevier Inc. 623
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Disruption of Mek1 and Mek2 in TissueFigure 6. Knockdown of Mek1 and Mek2 Collectively, but Not Individually, Leads to Reduced Proliferation and Hypoplasia in
Regenerated Human Skin
(A) Western blot of cultured human keratinocyte extracts 5 days after electroporation with the siRNA oligomers indicated above each column.
(B) Mean mitotic index of human skin grafts regenerated on immune deficient mice from keratinocytes treated with siRNA oligomers indicated at left
(n = 4 independent grafts per genotype ± SD).
(C) Human epidermal tissue harvested 6 days after grafting and stained with antibodies to Ki-67, keratin 5, and keratin 10 (orange), as well as human
species-specific antibody to desmoglein 3 (Dsg3, green); Hoechst 33342 nuclear stain (blue). The scale bars represent 50 mm.624 Developmental Cell 12, 615–629, April 2007 ª2007 Elsevier Inc.
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Disruption of Mek1 and Mek2 in TissueFigure 7. Expression of Active Erk2 Rescues the Effects of Mek1/2 Deficiency in Regenerated Human Skin
(A) Western blot of cultured human keratinocyte extracts 7 days after transduction with retroviral expression vectors encoding either active Erk2 or
LacZ control and 5 days after electroporation with the siRNA oligomers indicated above each column.
(B) Mean mitotic index of human epidermal tissue regenerated from keratinocytes transduced with either LacZ or active Erk2 that also received siRNA
oligomers to either both Mek1 and Mek2 or scrambled control (n = 4 independent grafts per genotype ± SD).
(C) Human skin grafts stained with antibodies to Ki-67, keratin 5, and keratin 10 (orange); desmoglein 3 (Dsg3, green); Hoechst 33342 nuclear stain
(blue). The scale bars represent 50 mm.Developmental Cell 12, 615–629, April 2007 ª2007 Elsevier Inc. 625
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Disruption of Mek1 and Mek2 in Tissuereplaced by downstream induction of Erk MAPK activity in
this setting.
DISCUSSION
Here we have investigated the genetic interactions and
functional overlap of Mek1 and Mek2 in vivo, in the setting
of a self-renewing mammalian tissue, epidermis. Absence
of either protein alone produced no detectable phenotype,
either at birth or in adulthood, even in the setting of wound
healing, which has been associated with increased Erk
MAPK induction (Tscharntke et al., 2005). Further, we
demonstrate that a single Mek allele, whether Mek1 or
Mek2, is sufficient for murine epidermal development
and survival. In contrast, combined disruption of Mek1
and Mek2 is lethal.
Mek1/2 double knockout animals die within 24 hr after
birth with characteristic signs of impaired barrier function
and dehydration. Although double knockout epidermis
was hypoplastic at birth, it retained expression of markers
characteristic of all epidermal layers. This suggests that
induction of Mek1/2 deficiency in midgestation, when
the keratin 14 promoter-driven Cre becomes active,
does not globally disrupt epidermal tissue polarity. Some
gaps in epidermal expression of terminal differentiation
proteins were seen in the context of total Mek1/2 absence,
however, suggesting abnormalities in cellular contribu-
tions to the cornified permeability barrier, possibly due
to focal defects in cell viability. During late embryogenesis,
double knockout epidermis displayed a decrease in prolif-
eration and increase in apoptosis, providing a potential
explanation for the epidermal hypoplasia noted at birth.
As demonstrated in skin allograft experiments, however,
Mek1/2 null epidermis underwent complete cell death in
the days following birth, indicating that these proteins
are required for tissue viability in the postnatal period. In
adulthood, inducible deletion of Mek1 on a Mek2 null
background led to hypoproliferation, massive epidermal
apoptosis, and lethality, accompanied by induction of
markers associated with the mitochondrial death path-
way. Therefore, Mek1/2 loss of function in stratified epi-
thelial tissue can lead to decreased proliferation and in-
creased apoptosis, depending on the setting.
The epidermal hypoplasia observed in Mek1/2 double
knockout mice mirrored that seen in epidermal growth
factor receptor (EGFR) knockout mice, consistent with
a model in which signals acting to maintain epidermal
growth are transmitted from extracellular receptors to
the Erk MAPK pathway via Ras (Dajee et al., 2002; Mietti-
nen et al., 1995). EGFR knockout mice exhibit thin skin, in-
frequent and bulbous hair follicles, and open eyes at birth,
similar to Mek1/2 double knockout mice, suggesting that
EGFR’s effects on epidermal homeostasis are largely me-
diated by Mek1/2. Interestingly, however, EGFR-deficient
skin does not display the profound deficits in viability seen
with Mek1/2 loss. EGFR and other receptor tyrosine ki-
nases commonly engage the Erk MAPK pathway via Ras
signaling to Raf. Our finding that conditional Raf activation
fails to successfully induce proliferation in mammalian tis-626 Developmental Cell 12, 615–629, April 2007 ª2007 Elseviersue when Mek1/2 are absent is consistent with the cas-
cade model in which signal transmission to downstream
Raf targets proceeds via Mek1/2.
Mek1 and Mek2 represent the only known activators of
Erk1/2 (Schaeffer and Weber, 1999). Consistent with this,
Erk1/2 phosphorylation was abolished by Mek1/2 abla-
tion. This supports a classical model of linear signal trans-
mission in which blockade of Erk MAPK cascade function
at the level of the Mek1/2 would be expected to interrupt
Erk activation. Such a model would predict that restoring
function at the level of Erk would reverse the effects of
Mek1/2 loss. This is, in fact, what we observed in regener-
ated human epidermis, where RNAi-based Mek1/2 deple-
tion led to profound hypoproliferation and tissue hypo-
plasia, which could be fully reversed by active Erk2
expression. Unlike murine genetic experiments, these hu-
man skin experiments did not examine the effects of
Mek1/2 loss in either development or stably self-renewing
adult epidermis, but rather in the setting of tissue regener-
ation. These human tissue regeneration experiments thus
complement murine loss-of-function genetics as an ap-
proach to examine Erk MAPK function in tissue.
The specific Erk targets, among the more than 160 so
far identified, that mediate Erk MAPK pathway effects on
epidermal proliferation and survival are unknown at pres-
ent. The Erk MAPK pathway is a classical driver of G1 cell-
cycle progression via mechanisms such as increased
cyclin D expression (Lavoie et al., 1996; Weber et al.,
1997). It also promotes cell growth, acting through CPSII
to enhance nucleotide synthesis, Mnk1 to increase protein
synthesis, and histone H5 to facilitate gene expression
(Whitmarsh and Davis, 2000). A number of specific anti-
apoptotic actions of the Erk MAPK cascade have also
been identified. These include inhibitory phosphorylation
on serine 112 of the pro-apoptotic protein BAD (She
et al., 2005; Zha et al., 1996), an event which inhibits death
via the mitochondrial pathway by promoting BAD seques-
tration and unimpaired Bcl-2 anti-apoptotic function. Con-
sistent with a potential impact of Erk MAPK action on BAD
in epidermal tissue, conditional ablation of Mek function in
adult tissue substantially reduced phosphorylation of BAD
on serine 112; further studies are necessary, however, to
establish a functional role for BAD in this setting. The iden-
tity of potential Erk MAPK effectors in epidermis and the
question of whether single or divergent effector pathways
operate immediately downstream of Erk to mediate these
distinct biological processes are areas of interest for
future study.
In summary, the Erk MAPK cascade is required for de-
velopment and maintenance of a self-renewing mamma-
lian tissue, epidermis. Total disruption of its function at
the level of Mek1/2 during either development or adult-
hood is lethal, demonstrating that Erk MAPK signaling
is necessary for survival in mammals. Consistent with
a role for canonical Mek targets in this process, active
Erk2 expression rescued defects caused by Mek1/2 defi-
ciency in human epidermis. Our results reveal an in vivo
functional overlap between Mek1 and Mek2 during normal
skin development. It will be interesting to investigateInc.
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other settings, such as tumorigenesis.
EXPERIMENTAL PROCEDURES
Mice
Mek2/ mice were maintained in a 129/SvEv background. In these
mice, a neomycin resistance gene cassette replaces the fifth exon of
Mek2, as well as parts of exons 4 and 6, which contain the kinase do-
main (Belanger et al., 2003). Mek1fl/fl mice were also generated in
a 129/SvEv background; in these mice, loxP sites flank Mek1 exon 3
(Bissonauth et al., 2006). RafER transgenic mice were kept in a 129/
SvEv background (Tarutani et al., 2003). K14-Cre transgenic mice
were obtained from Elaine Fuchs, Rockefeller University, New York
(Vasioukhin et al., 1999), and K14-CreER mice were provided by Pierre
Chambon, Institute for Genetics and Cellular and Molecular Biology,
Strasbourg, France (Li et al., 2000); each line was then backcrossed
to 129/SvEv mice. Mice were housed and bred under standard condi-
tions with food and water ad libitum and were maintained on a 12 hr
dark/light cycle. All experiments were approved by the Stanford Uni-
versity Animal Care and Use Committee.
Mouse Genotyping
Mouse genotyping was performed by Transnetyx (Cordova, TN) or by
PCR using genomic DNA isolated from mouse tails. Primers used for
gene amplification were: 50-TTGGGGAAGGTCAGCATTGC-30 and 50-
GCCGCTCACCCCGAAGTCAC-30 for wild-type Mek2, 50-AGAGGC
TATTCGGCTATGACT-30 and 50-GCACGAG GAAGCGGTCAGCCC-
30 for neomycin resistance gene (Mek2 null allele), 50-ATT TGCCT
GCATTACCGGTC-30 and 50-ATCAACGTTTTCTTTTCGG-30 for Cre or
CreER, and 50-TCTGCATGCCTTTATACA-30 and 50-CATA GCAATTG
ACGACTAA-30 for DMek1, the product of Cre- or CreER-mediated re-
combination of the floxed Mek1 allele. To amplify the floxed Mek1
allele, 50-CACAAGTTCCCACGACACTA-30 and 50-GTCTGTCACTTG
TCTTCTGG-30 were used as primers; in this reaction, a 373 bp or
682 bp product is generated in the presence of a wild-type or floxed
Mek1 allele, respectively. RafER construct was detected with the
following primers: 50-CGTGCTGGTTATTGTGCTGTCTC-30 and 50-
AACCTGCTGAGAACCACTC-30.
Skin Barrier Assays
To perform X-gal staining, unfixed, untreated newborn mice or em-
bryos were washed in phosphate-buffered saline (PBS) and then incu-
bated overnight at 37C in 5-bromo-4-chloro-3-indlyl-b-D-galactopyr-
anoside (X-gal) reaction mix (100 mM NaPO4, 1.3 mM MgCl2, 3 mM
K3Fe[CN]6, 3 mM K4Fe[CN]6, and 1 mg/ml X-gal [pH 4.5]). At pH 4.5,
the skin exhibits endogenous b-galactosidase activity, so increased
X-gal staining indicates epidermal permeability to X-gal, a sign of com-
promised barrier function (Hardman et al., 1998). Transepidermal
water loss across the ventral skin of newborn mice was measured
using an evaporimeter (Servomed, Stockholm, Sweden).
Wound Healing Experiments
Two round, full-thickness excision wounds, 4 mm in diameter, were
made on the dorsal skin of anesthetized 10- to 12-week-old mice using
sterile biopsy punches. The untreated wounds were measured daily.
Grafting of Mouse Skin onto Immune-Deficient Mice
Skin from newborn or 5- to 6-week-old mice was harvested, stored
overnight at 4C in PBS with 100 U/ml penicillin and 100 mg/ml strep-
tomycin, and then grafted onto female 10- to 12-week-old CB-17 scid
mice (Charles River, Wilmington, MA). Grafts of newborn skin were
harvested 11 days after surgery. Grafts of adult skin were maintained
for 4 months after surgery, at which point they were treated with 4-hy-
droxytamoxifen (4OHT) or ethanol for 3 weeks and then harvested.DeveloIsolation of Mouse Keratinocytes
Newborn mice were sacrificed immediately after birth, at which point
their skin was removed and incubated in dispase (Invitrogen, Carlsbad,
CA) at 4C overnight. Subsequently, the epidermis was peeled from
the dermis and incubated for 10 min in trypsin at 37C. The resulting
epidermal cells were lysed and used for western blotting.
RNA Interference in Regenerated Human Skin
Small interfering RNA (siRNA) oligomers against Mek1 and Mek2 were
designed and synthesized by Dharmacon (Chicago). A Dharmacon
scrambled siRNA oligomer was used as a control. In knockdown ex-
periments, an Amaxa nucleofection kit (Amaxa, Gaithersburg, MD)
was used to electroporate 106 keratinocytes with either 1.4 nmol of
control oligomer, 1.4 nmol of Mek1 oligomer, 1.4 nmol of Mek2 oligo-
mer, or 0.7 nmol of both Mek1 and Mek2 oligomers. To regenerate
human skin using siRNA-treated cells, a rapid graft method was de-
veloped: electroporated cells were seeded onto 2 cm2 pieces of
devitalized human dermis and cultured for 48 hr in keratinocyte growth
medium, at which point the pieces were grafted onto 8- to 10-week-old
female CB-17 scid mice. The skin grafts were harvested 6 days after
surgery. For rescue experiments, cells were infected with LZRS-Erk2
as previously described (Scholl et al., 2004). This retroviral vector
was constructed by cloning an active form of Erk2 (L73P/S151D) ob-
tained from Nathalie Ahn, University of Colorado, Boulder (Emrick
et al., 2001), into the XbaI/EcoRI sites of pENTR1A, from which it
was transferred into the LZRS vector by an LR Clonase reaction (Gate-
way Technologies, Carlsbad, CA). For protein analysis, electroporated
cells were cultured in keratinocyte serum-free medium (GIBCO, Carls-
bad, CA) for 5 days, and then harvested for western blot analysis.
Western Blot
For immunoblotting, cells were lysed in 20 mM Tris (pH 7.5), 150 mM
NaCl, 1 mM EDTA, and 1% NP40 supplemented with protease inhib-
itor (Complete Mini EDTA-free; Roche, Indianapolis, IN) and phospha-
tase inhibitor mixture II (Sigma-Aldrich, St. Louis, MO). Twenty-five mi-
crograms of protein per lane was run on a denaturing 12% SDS-PAGE
gel and subsequently transferred to PVDF membranes via semidry
transfer. For blocking and antibody dilution, Superblock (Pierce, Rock-
ford, IL) was used. Antibodies used for immunoblotting included rabbit
anti-Mek1 and rabbit anti-Mek2 (1:1,000; Santa Cruz Biotechnology,
Santa Cruz, CA); rabbit anti-phospho-p44/42 MAPK and rabbit anti-to-
tal-p44/42 MAPK (1:1,000; Cell Signaling Technologies, Danvers, MA);
rabbit anti-Cre (1:10,000; Novagen, Madison, WI); and goat anti-b-
actin (1:10,000; Santa Cruz Biotechnology). Secondary antibodies in-
cluded donkey anti-rabbit IgG and sheep anti-mouse IgG conjugated
to horseradish peroxidase (HRP) (1:20,000; Amersham Biosciences,
Piscataway, NJ), as well as bovine anti-goat HRP (1:10,000; Santa
Cruz Biotechnology). Pierce Supersignal Pico, Femto, and Dura
(Pierce) were used for detection. For developing, Kodak XAR Biomax
film (Kodak, Rochester, NY) and Amersham Hyperfilm (Amersham Bio-
sciences) were used. To detect multiple proteins, membranes were
treated in stripping buffer (100 mM b-mercaptoethanol, 2% SDS,
and 62.5 mM Tris [pH 6.8]) and then reprobed.
Histopathology and Immunohistochemistry
Dorsal skin was dissected, fixed in 10% neutral buffered formalin (Ac-
custain; Sigma-Aldrich), and embedded in paraffin, from which 5 mm
sections were cut and stained with hematoxylin and eosin (H&E) or
by immunohistochemistry according to standard methods. Permeabi-
lization for antigen retrieval was performed by microwaving samples in
0.01 M citrate buffer at pH 6.0. The sections were then stained with
rabbit anti-BAD (1:50; Cell Signaling Technologies) or rat anti-Ki-67
(1:100; Dako, Carpinteria, CA) primary antibody and donkey anti-rabbit
or donkey anti-rat biotin (1:1,000; Jackson ImmunoResearch Labora-
tories, West Grove, PA) secondary antibody; staining and develop-
ment were performed using the Vectastain ABC kit (Vector Laborato-
ries, Burlingame, CA) and Dako cytomation liquid DAB+ substratepmental Cell 12, 615–629, April 2007 ª2007 Elsevier Inc. 627
Developmental Cell
Disruption of Mek1 and Mek2 in Tissuechromogen system (Dako). A minimum of three specimens was ana-
lyzed per genotype.
Immunostaining
For each of the following genotypes, specimens were prepared from
at least three independent animals and stained simultaneously: wild-
type, Mek1fl/fl, Mek1fl/+Cre, Mek1fl/flCre, Mek2+/, Mek2/, Mek1fl/+
Mek2+/, Mek1fl/flMek2+/, Mek1fl/+Mek2/, Mek1fl/flMek2/,
Mek1fl/+Mek2+/Cre, Mek1fl/flMek2+/Cre, Mek1fl/+Mek2/Cre, and
Mek1fl/flMek2/Cre. Tissue was frozen in OCT (Sakura Finetek, Tor-
rance, CA) and cut into 7 mm cryosections, which were then fixed either
in room temperature 4% paraformaldehyde for 20 min followed by 30
min in PBS and 2 min in 100% ethanol or in 20C acetone for 10 min.
Sections were blocked with 10% horse serum in PBS, incubated in 2%
horse serum and primary antibody in PBS, washed with PBS, and,
finally, incubated in a solution of 2% horse serum, secondary antibody,
and 2 mg/ml Hoechst 33221 nuclear dye in PBS (Molecular Probes,
Carlsbad, CA); all incubations were 1 hr at room temperature. Slides
were mounted in Prolong Gold mounting medium (Molecular Probes)
and viewed using a Zeiss 100M Axiovert microscope (Thornwood,
NY). Antibodies used for immunostaining included rabbit anti-mouse
K5 (1:1,000), rabbit anti-mouse K6 (1:500), rabbit anti-mouse K10
(1:500), rabbit anti-mouse K14 (1:1,000), and rabbit anti-mouse loricrin
(1:500) (Covance, Berkeley, CA); rat anti-mouse Ki-67 (1:100; Dako);
rabbit anti-human Ki-67 (1:100; NeoMarkers, Fremont, CA); anti-
mouse b4 integrin (1:100; BD Pharmingen, San Jose, CA); rabbit
anti-mouse Mek1 and rabbit anti-mouse Mek2 (1:250; Epitomics, Bur-
lingame, CA); rabbit anti-mouse cytochrome c and rabbit anti-mouse
active caspase 9 (1:100; Cell Signaling Technologies); rabbit anti-
mouse active caspase 3 (1:250; R&D Systems, Minneapolis, MN); rab-
bit anti-mouse active caspase 8 (1:5,000; IMGENEX, San Diego, CA);
rabbit anti-mouse p-BAD (Ser112) (1:50; Cell Signaling Technologies);
and mouse anti-human desmoglein 3 (1:200; Zymed, South San Fran-
cisco, CA). Secondary antibodies included Cy3 donkey anti-rat IgG
and Cy3 donkey anti-rabbit IgG (1:100; Jackson ImmunoResearch
Laboratories) and goat anti-mouse AlexaFluor488 (1:500; Invitrogen).
TUNEL assays were performed on tissue sections as recommended
by the manufacturer (Roche Diagnostics).
Statistics
ANOVA and subsequent post hoc analyses using Student’s t test were
used to assess transepidermal water loss, epidermal cell number, hair
follicle number, and proportions of TUNEL- and Ki-67-positive cells.
Supplemental Data
Supplemental Data include six figures and are available at http://www.
developmentalcell.com/cgi/content/full/12/4/615/DC1/.
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